清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Is glucose the scapegoat for tumor evasion?

谷氨酰胺 肿瘤细胞 髓系细胞 肿瘤微环境 糖酵解 替罪羊 逃避(道德) 癌症研究 葡萄糖转运蛋白 厌氧糖酵解 癌症 髓样 细胞生物学 癌变 生物 新陈代谢 免疫学 生物化学 氨基酸 内分泌学 免疫系统 胰岛素 政治学 法学
作者
Lydia Raines,Stanley Ching-Cheng Huang
出处
期刊:Cancer Cell [Cell Press]
卷期号:39 (7): 907-909 被引量:6
标识
DOI:10.1016/j.ccell.2021.06.006
摘要

Tumor cells undergo rapid aerobic glycolysis to fuel growth and proliferation. A recent finding in Nature reveals that tumor-infiltrating myeloid cells demonstrate greater capacity for glucose uptake than tumor cells and consume significant amounts within the tumor milieu. Unexpectedly, tumor cells account for the highest glutamine utilization in the tumor microenvironment. Tumor cells undergo rapid aerobic glycolysis to fuel growth and proliferation. A recent finding in Nature reveals that tumor-infiltrating myeloid cells demonstrate greater capacity for glucose uptake than tumor cells and consume significant amounts within the tumor milieu. Unexpectedly, tumor cells account for the highest glutamine utilization in the tumor microenvironment. A fundamental notion of cancer biology may be flipped on its head. For decades, the field of cancer biology has understood that cancer cells undergo a metabolic phenomenon called the Warburg effect, in which cancer cells preferentially catabolize glucose through glycolysis even when abundant oxygen is present (Vander Heiden et al., 2009Vander Heiden M.G. Cantley L.C. Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation.Science. 2009; 324: 1029-1033Crossref PubMed Scopus (9348) Google Scholar). While inefficient in terms of net ATP output, aerobic glycolysis allows the tumor cells to quickly generate energy and intermediate metabolites, leading to rapid growth and proliferation (Vander Heiden et al., 2009Vander Heiden M.G. Cantley L.C. Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation.Science. 2009; 324: 1029-1033Crossref PubMed Scopus (9348) Google Scholar). With considerable attention focused on metabolism research and the understanding that cellular phenotypes and activity are intimately linked, one current trend in cancer research is to understand how manipulation of either tumor or immune cell metabolic programs can further improve the effectiveness and efficacy of cancer therapy. Moreover, cellular metabolism is further dependent on the availability of nutrients that fuel all of our internal metabolic processes. As such, in addition to overall metabolism, nutrient availability or partitioning within the tumor microenvironment could have a direct impact on whether our immune cells help or hinder an anti-tumor response. So what is happening to the nutrients in the tumor microenvironment? With the prevailing conception being that cancer cells devour glucose rapidly through Warburg glycolysis, it can seem counterintuitive that the nutrient most consumed within the tumor microenvironment is not glucose but rather the amino acid glutamine. And yet, that is just what Reinfeld et al. uncover in a new study published in Nature (Reinfeld et al., 2021Reinfeld B.I. Madden M.Z. Wolf M.M. Chytil A. Bader J.E. Patterson A.R. Sugiura A. Cohen A.S. Ali A. Do B.T. et al.Cell-programmed nutrient partitioning in the tumour microenvironment.Nature. 2021; 593: 282-288Crossref PubMed Scopus (116) Google Scholar). Using PET tracers, Reinfeld et al. measured glucose intake in both tumor cells and immune cells infiltrating in the tumor niche. This study reveals that tumor-infiltrating immune cells, in particular the myeloid cells which make up the innate immune system, are able to take up substantial amounts of glucose. In fact, the PET studies reveal that myeloid cells have a higher capacity for glucose uptake when compared to the cancer cells and account for a significant portion of the glucose consumption within the tumor microenvironment (∼30% of available glucose). This being said, tumor cells still consume the majority of the glucose (60%) within the tumor microenvironment due to the greater number of tumor cells compared to immune cells (Figure 1). Mechanistic target of rapamycin (mTOR) is a protein kinase that integrates nutrient availability and growth factor-and immune factor-initiated signaling (Liu and Sabatini, 2020Liu G.Y. Sabatini D.M. mTOR at the nexus of nutrition, growth, ageing and disease.Nat. Rev. Mol. Cell Biol. 2020; 21: 183-203Crossref PubMed Scopus (559) Google Scholar). Having observed that both myeloid and tumor cells take up the most glucose, Reinfeld et al. sought to determine whether this uptake was mediated by mTOR. Gene set enrichment analyses showed a significant enrichment of glucose-related pathways in both tumor and myeloid cells, and using Rapamycin to inhibit mTOR activity results in a significant loss of fluorodeoxyglucose (FDG) uptake, especially in myeloid cells. Interestingly, rapamycin does not affect the mitochondrial fitness nor the glycolysis of cancer cells but has large inhibitory effects on myeloid cells. Furthermore, the cancer cells are also found to enrich pathways associated with lipid metabolism and amino acid synthesis and have high expression of Mycn, a proto-oncogene that has been shown to drive glutaminolysis (Figure 1). Tumor-bearing mice were then treated with 18F-Gln, a fluorescently labeled glutamine. In contrast to glucose, they find that tumor cells have a significantly higher capacity for glutamine uptake, consuming ∼85% of the available glutamine within the tumor microenvironment (Figure 1). Interestingly, inhibition of glutamine uptake results in enhanced glucose consumption by cells within the tumor niche, suggesting that nutrient acquisition could be more so determined by cell-intrinsic properties rather than by what nutrients are available extrinsically. Taken together, these stunning revelations by Reinfeld et al. open the door for a number of intriguing questions regarding the future of nutrient partitioning studies within the tumor microenvironment. First, the role of myeloid cells within the tumor milieu has been of interest to tumor immunologists for some time. In particular, myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) have been the subject of much research due to their highly immunosuppressive properties and pro-tumoral effector function (Noy and Pollard, 2014Noy R. Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy.Immunity. 2014; 41: 49-61Abstract Full Text Full Text PDF PubMed Scopus (2128) Google Scholar; Veglia et al., 2021Veglia F. Sanseviero E. Gabrilovich D.I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.Nat. Rev. Immunol. 2021; https://doi.org/10.1038/s41577-020-00490-yCrossref PubMed Scopus (158) Google Scholar). And while MDSCs and TAMs are metabolically active cells, their role in nutrient sequestration has been critically overlooked—especially since glucose consumption is not often strongly associated with these particular cell types. Indeed, in terms of macrophage polarization, high glucose consumption is often attributed to pro-inflammatory (or M1) macrophages, which are often lowly presented within the tumor microenvironment (Noy and Pollard, 2014Noy R. Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy.Immunity. 2014; 41: 49-61Abstract Full Text Full Text PDF PubMed Scopus (2128) Google Scholar). However, anti-inflammatory (or M2) macrophages also require glucose. It has been reported that M2 macrophages increase glycolytic activity compared with naive macrophages, and this enhanced glucose utilization is necessary for M2 polarization (Huang et al., 2016Huang S.C.-C. Smith A.M. Everts B. Colonna M. Pearce E.L. Schilling J.D. Pearce E.J. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation.Immunity. 2016; 45: 817-830Abstract Full Text Full Text PDF PubMed Scopus (293) Google Scholar). Moreover, this utilization is mTORC2 dependent, with loss of mTORC2 in macrophages leading to enhanced anti-tumor immunity. This may suggest that treatments targeting glucose in the tumor microenvironment could work to inhibit immunosuppressive TAM differentiation. In addition to tumor-infiltrating myeloid cells, these findings call to question whether the oncogenic driver of a particular cancer instructs nutrient acquisition and whether the natural partitioning of the tissue environment itself could influence which nutrients are preferentially utilized. Previously, two excellent studies found that T cell dysfunction is driven in part by restricted glucose availability within the tumor microenvironment (Chang et al., 2015Chang C.-H. Qiu J. O’Sullivan D. Buck M.D. Noguchi T. Curtis J.D. Chen Q. Gindin M. Gubin M.M. van der Windt G.J.W. et al.Metabolic competition in the tumor microenvironment is a driver of cancer progression.Cell. 2015; 162: 1229-1241Abstract Full Text Full Text PDF PubMed Scopus (1421) Google Scholar; Ho et al., 2015Ho P.-C. Bihuniak J.D. Macintyre A.N. Staron M. Liu X. Amezquita R. Tsui Y.-C. Cui G. Micevic G. Perales J.C. et al.Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses.Cell. 2015; 162: 1217-1228Abstract Full Text Full Text PDF PubMed Scopus (731) Google Scholar). Interestingly, the tumor models used in these studies are driven by the oncogenes KRAS and BRAF, which are known to be associated with enhanced glycolytic metabolism (Nagarajan et al., 2016Nagarajan A. Malvi P. Wajapeyee N. Oncogene-directed alterations in cancer cell metabolism.Trends Cancer. 2016; 2: 365-377Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar). This offers one potential avenue of study: do the oncogenes which drive tumorigenesis also contribute to nutrient partitioning? The fact that the Myc oncogene present in Reinfeld et al.’s tumor models is associated with glutaminolysis, and that glutamine was the highest nutrient consumed, it could stand to reason that the oncogenic driver of a tumor could potentially determine how nutrients are partitioned within the extracellular environment. Should this be the case, it could mean that metabolic therapies should be tailored for the primary metabolic pathways that are perturbed. Furthermore, nutrient availability and/or preferences differ based on the tissue niche. A comprehensive study by Jang et al. mapping metabolite production and consumption in mammals demonstrates surprising organ specificity (Jang et al., 2019Jang C. Hui S. Zeng X. Cowan A.J. Wang L. Chen L. Morscher R.J. Reyes J. Frezza C. Hwang H.Y. et al.Metabolite exchange between mammalian organs quantified in pigs.Cell Metab. 2019; 30: 594-606Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar). It would, therefore, be interesting to see if the specific preference for certain nutrients is present in disparate tissue regions and results in different tumor metabolic rewiring. This work by Reinfeld et al. demonstrates that both tumors and immune cells take up nutrients within the tumor microenvironment, although at vastly different rates and amounts. This highlights the fact that different cellular subpopulations have different metabolic needs and thus acquire specific nutrients preferentially. Coupled with the vast heterogeneity of tumors and tissues, much consideration and further research will be needed to determine how these findings can be utilized to enhance cancer therapies. The authors declare no competing interests.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cyj完成签到 ,获得积分10
1秒前
打打的应助被Wang采纳,获得10
14秒前
22秒前
28秒前
勤劳的翩跹完成签到,获得积分10
28秒前
文静的丹彤完成签到,获得积分10
29秒前
TingtingGZ发布了新的文献求助10
32秒前
蓝意完成签到,获得积分0
34秒前
李健的应助被TingtingGZ采纳,获得10
39秒前
英姑的应助被TingtingGZ采纳,获得10
39秒前
科研通AI6.2的应助被TingtingGZ采纳,获得10
39秒前
上官若男的应助被TingtingGZ采纳,获得10
40秒前
Hello的应助被TingtingGZ采纳,获得10
40秒前
科研通AI65的应助被TingtingGZ采纳,获得10
40秒前
万能图书馆的应助被TingtingGZ采纳,获得10
40秒前
molihuakai的应助被TingtingGZ采纳,获得10
40秒前
李健的小迷弟的应助被TingtingGZ采纳,获得30
40秒前
GingerF的应助被TingtingGZ采纳,获得200
40秒前
47秒前
快乐的稚晴完成签到,获得积分10
56秒前
紫熊完成签到,获得积分10
1分钟前
热情菲鹰完成签到,获得积分10
1分钟前
Luoyan完成签到,获得积分10
1分钟前
1分钟前
优雅的傲柏完成签到,获得积分10
1分钟前
1分钟前
我想进步完成签到,获得积分10
1分钟前
坚强含烟完成签到,获得积分10
1分钟前
龙龙发布了新的文献求助10
1分钟前
1分钟前
1分钟前
随心所欲完成签到 ,获得积分10
1分钟前
Ava的应助被龙龙采纳,获得10
1分钟前
怕孤单的雪瑶完成签到,获得积分10
1分钟前
陈荆洲完成签到,获得积分10
2分钟前
2分钟前
从容的绿蝶完成签到,获得积分10
2分钟前
如意夏寒完成签到,获得积分10
2分钟前
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780476
捐赠科研通 7767279
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476682